DSP Healthcare Fund · Regular · Growth
NAV
₹45.5370
as of 29 Sept 2026
Expense Ratio
2.05%
AUM
₹3,218 Cr
Lumpsum returns (CAGR)
- 1Y
- +18.80%
- 3Y
- +20.10%
- 5Y
- +14.33%
- Since Inception
- +21.36%
SIP returns (XIRR)
- 1Y
- +25.11%
- 3Y
- +15.52%
- 5Y
- +18.21%
- Since Inception
- +20.38%
Returns calculated from 12 November 2018 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 5 years (Oct 2021 – Sept 2026)
A ₹5,000 monthly SIP for the last 5 years (Oct 2021 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹4,62,200 today — ₹2,95,000 invested, 18.5% XIRR.
₹2,95,000
Invested
₹4,62,200
Value today
18.5%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Oct 2021 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹1,94,794 today (14.3% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Oct 2021 would still hold ₹14,85,740.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹4,62,200 in this fund vs ₹3,59,448 in the benchmark — outperformance of ₹1,02,752.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Oct 2021 – Sept 2026) (3 Jun 2024) would be ₹1,43,000 today (1.43×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.67
Sharpe Ratio
+0.13
Alpha
0.19
Beta
0.64
Sortino
12.80%
Std Dev
-12.50%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology67.28%
- Healthcare Services20.36%
- Healthcare Equipment & Supplies7.51%
- Insurance0.99%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about DSP Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with DSP Healthcare Fund - Regular Plan - IDCW
- 1Ipca Laboratories Limited8.74%
- 2Sun Pharmaceutical Industries Limited7.95%
- 3Sai Life Sciences Limited7.45%
- 4Cipla Limited7.35%
- 5Apollo Hospitals Enterprise Limited6.47%
- 6Gland Pharma Limited5.98%
- 7Globus Medical Inc5.44%
- 8Divi'S Laboratories Limited4.15%
- 9Alkem Laboratories Limited4.08%
- 10Cohance Lifesciences Limited3.81%
What this fund does
DSP Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
DSP Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by DSP Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹3,218 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 2.05%.